← Back
▼ SELL 10b5-1 Plan

$ Value

$272K

Shares

1,179

Price

$231

Filed

Feb 4

Insider

Name

Fesko John

Title

PRESIDENT, CHIEF BUS. OFFICER

CIK

0002010135

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

180,496

Footnotes

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025. | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 30, 2026.

Filing Info

Accession No.

0002010135-26-000005

Form Type

4

Issuer CIK

0001604821

Fesko John's History

Date Ticker Type Value
2026-03-10 NTRA $144K
2026-03-09 NTRA A
2026-02-27 NTRA A
2026-02-03 NTRA $272K
2026-02-03 NTRA $558K
2026-01-30 NTRA A
2026-01-28 NTRA $221K
2026-01-27 NTRA $189K
2026-01-21 NTRA $80K
2026-01-20 NTRA $4.2M

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.1M 2026-03-10